Rare cystic fibrosis mutations limit the benefits of targeted drugs
Mutations leading to cystic fibrosis in Latino patients may create treatment disparities, say School scientists
News & Announcements
Latest News
-
-
Desai and Szoka named fellows of the National Academy of Inventors
The two faculty members have spent their careers working to improve therapies to treat disease. -
Implantable bioartificial kidney achieves preclinical milestone
Scientists implanted a prototype kidney bioreactor in large animals without significant safety concerns. -
Donors unite to honor Toby Herfindal and his commitment to innovation in pharmacy
The Toby Herfindal Presidential Chair for Entrepreneurship and Innovation will be used to support faculty members and/or graduate students in the UCSF School of Pharmacy -
Assemi and Clinard assume new associate dean roles
Mitra Assemi and Valerie Clinard were appointed to new associate dean roles in the UCSF School of Pharmacy. Both roles support the School’s evolving doctor of pharmacy (PharmD) degree program. -
PharmD students see to Dean Guglielmo’s flu shot
Getting vaccinated for the flu not only lowers a person’s chance of getting sick, it also helps protect their whole community. -
Desai inducted into International Academy of Medical and Biological Engineering
Desai was recognized for being a “pioneer in the use of micro and nanoscale materials to deliver protein and cell-based therapeutics.” -
School of Pharmacy leads in LivingGreen certifications
The School’s Dean’s Office received Platinum LivingGreen certification for reducing waste, energy, and water usage. -
For UCSF graduate, DACA gives a chance to fight cancer
Ku earned his PhD this spring in Pharmaceutical Sciences and Pharmacogenomics (PSPG) from UC San Francisco. -
The Kidney Project earns KidneyX award to make home dialysis better for patients
A team led by Shuvo Roy, PhD, recently won an award that will fund the development of an easy-to-use, safe, and effective home dialysis system. -
School reflects on legacy of achievement at Alumni Weekend 2019
Students, faculty, staff, and alumni celebrated the School of Pharmacy's long history of achievement in the discovery and clinical sciences, and clinical practice, at Alumni Weekend 2019. -
Training computers to think more like scientists
Michael Keiser, PhD, and Kangway Chuang, PhD, want to use machine learning to speed the pace of drug discovery. By digging into the work of another lab, the pair realized how machine learning could lead scientists astray—and came up with methods to avoid its worst pitfalls. -
Kortemme and Desai honored at annual meeting of the American Institute for Medical and Biological Engineering
School of Pharmacy faculty members Tanja Kortemme and Tejal Desai both received honors at the annual meeting of the American Institute for Medical and Biological Engineering. -
2019 Koda-Kimble Seed Award supports School of Pharmacy’s boldest ideas
The 2019 Mary Anne Koda-Kimble Seed Award for Innovation will fund nine bold research projects, ranging from studies of the molecular underpinnings of cancer to focus groups designed to prepare PharmD students for experiential learning. -
Desai named the director of new UCSF bioengineering initiative
The Health Innovation Via Engineering (HIVE) program is designed to inspire collaborations in bioengineering research. -
School of Pharmacy tops pharmacy schools in NIH funding for 39th straight year
Among all U.S. pharmacy schools, the UCSF School of Pharmacy earned the most research funding from the National Institutes of Health in 2018, totaling nearly $29 million dollars that will support studies spanning the basic to the clinical sciences. -
USP/UCSF fellowship to support research in the quality and safety of medical products
A new fellowship, funded jointly by UCSF-Stanford CERSI and the U.S. Pharmacopeial Convention (USP), will support research into the inactive components of medications, which are known as excipients. -
Gift of $500,000 honors Jere E. Goyan, late UCSF School of Pharmacy dean
The endowment will provide funds for a recipient to focus on delivering breakthroughs in therapeutics-related research, education, and patient care.